Report covers clinical trials for Mycosis Fungoides involving Bristol-Myers Squibb, Johnson & Johnson, Merck, and Novartis.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Bristol-Myers Squibb and Özlem Türeci presented late-stage oncology pipeline data and joint development activity in Mainz.Mon 13:24
  • Companies are pouring billions into protein degraders, a drug class that has received FDA approval and is being discussed by ASCO.Thu 17:40
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Failures resulted in catastrophic reputational damage for several major companies, while others successfully used safety as a brand differentiator.Tue 09:30
  • AppLovin fears being in Alphabet's crosshairs, while Compass Pathways avoids Johnson & Johnson due to size.Tue 01:20
• Merck →

  public company in Indonesia

  • The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.Tue 00:53
  • Moderna and Merck reported a landmark result from their melanoma study, while SanDisk and Dell were discussed in stock market analysis.Sun 06:35
• Novartis →

  Swiss-American multinational pharmaceutical corporation

  • Biotech and pharmaceutical companies in Greater Boston are seeing strategic investments, talent movement, and antibody development advances.Tue 13:27
  • Sean Maenpaa, with experience at Novartis and Celgene, was appointed SVP Business Development at Clovis Oncology.Fri 12:53